Indications for HBV Treatment
Which Patients With Hepatitis B Should We Be Treating?

Released: November 29, 2023

Ira Jacobson
Ira Jacobson, MD
Tatyana Kushner
Tatyana Kushner, MD, MSCE
Paul Y. Kwo
Paul Y. Kwo, MD

Activity

Progress
1
Course Completed

Are we treating HBV early enough? Is it time to move the goalposts regarding the timing of treatment initiation? What are the potential benefits of earlier treatment?

To answer these questions, Ira M. Jacobson, MD, leads a panel discussion with Tatyana Kushner, MD, MSCE, and Paul Y. Kwo, MD, exploring which patients with HBV we should be treating, including a focus on:

  • Guideline-based treatment recommendations and their limitations
  • Data describing the relationship between viral suppression and HBV DNA integration
  • More expansive indications for HBV treatment based on virologic considerations